Fundraising Fox
/Companies
Sign in

Brainomix

Oxford, GB · 3 known investors

Find your way into Brainomix

Sign up to see every warm intro you have to Brainomix

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Brainomix team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Brainomix, a spin-out from the University of Oxford, develops AI-powered imaging biomarkers and software that help physicians interpret medical images to support clinical decisions.

AI & Machine LearningDigital HealthMedical Devices

Founders & leadership

MPMichalis Papadakis
Michalis PapadakisCEOMichalis Papadakis holds a PhD in neurosciences from UCL School of Pharmacy and a BSc in Biochemistry from Imperial College London. He previously served as Scientific Director of the preclinical stroke lab at the University of Oxford before founding Brainomix, a University of Oxford spin-out developing AI-powered medical imaging software for clinical decision support.
AB
Alastair BuchanCo-founder; Oxford Professor of Stroke Medicine

Investors · 3

Boehringer Ingelheim Venture FundreportedIngelheim am Rhein · $16.2M

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Parkwalk AdvisorsreportedLondon

How we know: a partner's Signal profile · Not right? Tell us

Funding

SEC filings, press & company announcements

$25.4M disclosed across 1 of 4 rounds · 2025–2026

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 1

MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.

Companies working in the same space as Brainomix.

Companies House · registry record

View on Companies House ↗
Registered name
BRAINOMIX LIMITED
Company number
07426406
Status
Active
Company type
Private limited company
Incorporated
2 Nov 2010
Registered office
First Floor Seacourt Tower, West Way, Oxford, OX2 0JJ
Nature of business (SIC)
62090 — Other information technology service activities
Accounts
last made up to 31 Dec 2025 · next due 30 Sept 2027
Confirmation statement
last made up to 10 Nov 2025 · next due 24 Nov 2026

Current officers · 5

  • Anna Victoria Griffin — secretary, appointed 1 Sept 2025
  • Khushro Fredoon Mehta — director, appointed 1 Apr 2025
  • Michail Papadakis — director, appointed 2 Nov 2010
  • Oliver Reuss — director, appointed 3 Dec 2021
  • Parkwalk Advisors Ltd — corporate director, appointed 20 Aug 2019

Source: Companies House public register · retrieved 16 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.

In the news

Brainomix Extends Series C Financing to $25.4M (£18.8M) to Support U.S. Expansionprnewswire.com · Feb 2026Brainomix Raises £14M in Series C Fundingfinsmes.com · Mar 2025

Frequently asked questions

What does Brainomix do?
Brainomix, a spin-out from the University of Oxford, develops AI-powered imaging biomarkers and software that help physicians interpret medical images to support clinical decisions.
Who founded Brainomix?
Brainomix was founded by Michalis Papadakis, Alastair Buchan.
Who are Brainomix's investors?
Brainomix's investors include Modi Ventures, Boehringer Ingelheim Venture Fund, Parkwalk Advisors.
How much funding has Brainomix raised?
Brainomix has disclosed $25.4M raised across 1 of its 4 known rounds.
Where is Brainomix headquartered?
Brainomix is headquartered in Oxford, GB.